MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/cpj.0000000000200312

Медицинская библиотека · Neurology. Clinical practice · 2024

Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States.

Matesanz Susan E, Edelson Jonathan B, Iacobellis Katherine A, Mejia Erika, Brandsema John F, Wittlieb-Weber Carol A, Okunowo Oluwatimilehin, Griffis Heather, Lin Kimberly Y

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVES

Standards of care exist to optimize outcomes in Duchenne and Becker muscular dystrophy (DBMD), caused by alterations in the DMD gene; however, there are limited data regarding health care access in these patients. This study aims to characterize outpatient subspecialty care utilization in pediatric patients with DBMD.

METHODS

This retrospective cohort study used administrative claims data from IBM MarketScan Medicaid and Commercial Claims and Encounters Research Databases (2013-2018). Male patients 1-18 years with an ICD-9/10 diagnosis code for hereditary progressive muscular dystrophy between January 1, 2013, and December 31, 2017, were included. Participants were stratified into 3 age cohorts: 1-6 years, 7-12 years, and 13-18 years. The primary outcome was rate of annual neurology visits. Secondary outcomes included annual follow-up rates in other subspecialties and proportion of days covered (PDC) by corticosteroids.

RESULTS

A total of 1,386 patients met inclusion-347 (25.0%) age 1-6 years, 502 (36.2%) age 7-12 years, and 537 (38.7%) age 13-18 years. Heart failure, respiratory failure, and technology dependence increased with age (p for all<0.05). The rate of neurology visits per person-year was 0.36 and did not differ by age. Corticosteroid use was low; 30% of person-years (1452/4829) had a PDC ≥20%. Medicaid insurance was independently associated with a lower likelihood of annual neurology follow-up (OR 0.23; 95% CI 0.18-0.28).

DISCUSSION: The rate of annual neurology follow-up and corticosteroid use in patients with DBMD is low. Medicaid insurance status was independently associated with a decreased likelihood of neurology follow-up, while age was not, suggesting that factors other than disease severity influence neurology care access. Identifying barriers to regular follow-up is critical in improving outcomes for patients with DBMD.

Для цитирования: Matesanz Susan E, Edelson Jonathan B, Iacobellis Katherine A, Mejia Erika, Brandsema John F, Wittlieb-Weber Carol A, Okunowo Oluwatimilehin, Griffis Heather, Lin Kimberly Y. Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States.. Neurology. Clinical practice. 2024. DOI: 10.1212/cpj.0000000000200312.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.